Shukra Pharmaceuticals Ltd

Pursuant to Regulation 32 of SEBI (listing Obligations and Disclosure Requirements) Regulation 2015 we hereby confirm that there is no deviation and/or variation in the utilization of proceeds from the object mentioned in the letter of offer dated February 01 2023 for Right Issue of 9394050 partly paid-up equity shares in which Rs. 5/- each was payable on application. It is further confirmed that the proceeds of 9394050 Partly Paid-up equity shares on a Right basis on during the Quarter and year ended 31st March 2023 have been fully utilized.